448 related articles for article (PubMed ID: 12140283)
1. Smad4/DPC4-dependent regulation of biglycan gene expression by transforming growth factor-beta in pancreatic tumor cells.
Chen WB; Lenschow W; Tiede K; Fischer JW; Kalthoff H; Ungefroren H
J Biol Chem; 2002 Sep; 277(39):36118-28. PubMed ID: 12140283
[TBL] [Abstract][Full Text] [Related]
2. Regulation of biglycan gene expression by transforming growth factor-beta requires MKK6-p38 mitogen-activated protein Kinase signaling downstream of Smad signaling.
Ungefroren H; Lenschow W; Chen WB; Faendrich F; Kalthoff H
J Biol Chem; 2003 Mar; 278(13):11041-9. PubMed ID: 12538652
[TBL] [Abstract][Full Text] [Related]
3. Suppression of tumorigenesis and induction of p15(ink4b) by Smad4/DPC4 in human pancreatic cancer cells.
Peng B; Fleming JB; Breslin T; Grau AM; Fojioka S; Abbruzzese JL; Evans DB; Ayers D; Wathen K; Wu T; Robertson KD; Chiao PJ
Clin Cancer Res; 2002 Nov; 8(11):3628-38. PubMed ID: 12429655
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-beta (TGF-beta) type I receptor/ALK5-dependent activation of the GADD45beta gene mediates the induction of biglycan expression by TGF-beta.
Ungefroren H; Groth S; Ruhnke M; Kalthoff H; Fändrich F
J Biol Chem; 2005 Jan; 280(4):2644-52. PubMed ID: 15546867
[TBL] [Abstract][Full Text] [Related]
5. Adhesion and Rac1-dependent regulation of biglycan gene expression by transforming growth factor-beta. Evidence for oxidative signaling through NADPH oxidase.
Groth S; Schulze M; Kalthoff H; Fändrich F; Ungefroren H
J Biol Chem; 2005 Sep; 280(39):33190-9. PubMed ID: 16051607
[TBL] [Abstract][Full Text] [Related]
6. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.
Poncelet AC; de Caestecker MP; Schnaper HW
Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488
[TBL] [Abstract][Full Text] [Related]
7. Induction of p21waf1 expression and growth inhibition by transforming growth factor beta involve the tumor suppressor gene DPC4 in human pancreatic adenocarcinoma cells.
Grau AM; Zhang L; Wang W; Ruan S; Evans DB; Abbruzzese JL; Zhang W; Chiao PJ
Cancer Res; 1997 Sep; 57(18):3929-34. PubMed ID: 9307274
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-beta repression of matrix metalloproteinase-1 in dermal fibroblasts involves Smad3.
Yuan W; Varga J
J Biol Chem; 2001 Oct; 276(42):38502-10. PubMed ID: 11502752
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional cross-talk between Smad, ERK1/2, and p38 mitogen-activated protein kinase pathways regulates transforming growth factor-beta-induced aggrecan gene expression in chondrogenic ATDC5 cells.
Watanabe H; de Caestecker MP; Yamada Y
J Biol Chem; 2001 Apr; 276(17):14466-73. PubMed ID: 11278290
[TBL] [Abstract][Full Text] [Related]
10. The TGF-beta signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer.
Kleeff J; Ishiwata T; Maruyama H; Friess H; Truong P; Büchler MW; Falb D; Korc M
Oncogene; 1999 Sep; 18(39):5363-72. PubMed ID: 10498890
[TBL] [Abstract][Full Text] [Related]
11. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
[TBL] [Abstract][Full Text] [Related]
12. Lack of responsiveness to TGF-beta1 in a thyroid carcinoma cell line with functional type I and type II TGF-beta receptors and Smad proteins, suggests a novel mechanism for TGF-beta insensitivity in carcinoma cells.
Heldin NE; Bergström D; Hermansson A; Bergenstråhle A; Nakao A; Westermark B; ten Dijke P
Mol Cell Endocrinol; 1999 Jul; 153(1-2):79-90. PubMed ID: 10459856
[TBL] [Abstract][Full Text] [Related]
13. Smad4/DPC4 silencing and hyperactive Ras jointly disrupt transforming growth factor-beta antiproliferative responses in colon cancer cells.
Calonge MJ; Massagué J
J Biol Chem; 1999 Nov; 274(47):33637-43. PubMed ID: 10559252
[TBL] [Abstract][Full Text] [Related]
14. Systematic analysis of the TGF-beta/Smad signalling pathway in the rhabdomyosarcoma cell line RD.
Wang H; Yang GH; Bu H; Zhou Q; Guo LX; Wang SL; Ye L
Int J Exp Pathol; 2003 Jun; 84(3):153-63. PubMed ID: 12974945
[TBL] [Abstract][Full Text] [Related]
15. Smads in human trophoblast cells: expression, regulation and role in TGF-beta-induced transcriptional activity.
Wu D; Luo S; Wang Y; Zhuang L; Chen Y; Peng C
Mol Cell Endocrinol; 2001 Apr; 175(1-2):111-21. PubMed ID: 11325521
[TBL] [Abstract][Full Text] [Related]
16. TGF-beta activated Smad signalling leads to a Smad3-mediated down-regulation of DSPP in an odontoblast cell line.
He WX; Niu ZY; Zhao SL; Jin WL; Gao J; Smith AJ
Arch Oral Biol; 2004 Nov; 49(11):911-8. PubMed ID: 15353247
[TBL] [Abstract][Full Text] [Related]
17. Tumor suppressor gene Smad4/DPC4, its downstream target genes, and regulation of cell cycle.
Chiao PJ; Hunt KK; Grau AM; Abramian A; Fleming J; Zhang W; Breslin T; Abbruzzese JL; Evans DB
Ann N Y Acad Sci; 1999 Jun; 880():31-7. PubMed ID: 10415848
[TBL] [Abstract][Full Text] [Related]
18. Sp1 and Smad proteins cooperate to mediate transforming growth factor-beta 1-induced alpha 2(I) collagen expression in human glomerular mesangial cells.
Poncelet AC; Schnaper HW
J Biol Chem; 2001 Mar; 276(10):6983-92. PubMed ID: 11114293
[TBL] [Abstract][Full Text] [Related]
19. Induction and expression of betaig-h3 in pancreatic cancer cells.
Schneider D; Kleeff J; Berberat PO; Zhu Z; Korc M; Friess H; Büchler MW
Biochim Biophys Acta; 2002 Oct; 1588(1):1-6. PubMed ID: 12379307
[TBL] [Abstract][Full Text] [Related]
20. Signaling through the Smad pathway by insulin-like growth factor-binding protein-3 in breast cancer cells. Relationship to transforming growth factor-beta 1 signaling.
Fanayan S; Firth SM; Baxter RC
J Biol Chem; 2002 Mar; 277(9):7255-61. PubMed ID: 11751851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
